Keyphrases
Paclitaxel
100%
Human Studies
100%
Drug Interactions
100%
Ketoconazole
100%
Experiment in Vitro
100%
Erythromycin
44%
Breath Test
44%
Plasma Concentration
33%
Pharmacokinetics
22%
Cytochrome P450 3A (CYP3A)
22%
Inter-patient Variability
22%
IC50
11%
Single Oral Dose
11%
Plasma Drug Concentration
11%
Concomitant Treatment
11%
Activity in Vivo
11%
50% Inhibitory Concentration
11%
Ultra-high Performance Liquid Chromatography (UHPLC)
11%
Dose Adjustment
11%
Derived Material
11%
Peak Plasma Concentration
11%
Inter-variability
11%
Ovarian Cancer Patients
11%
Metabolism in Vitro
11%
Continuous Intravenous Infusion
11%
Pharmacology, Toxicology and Pharmaceutical Science
Paclitaxel
100%
Drug Interaction
100%
Human Study
100%
Erythromycin
44%
IC50
22%
CYP3A
22%
Clinical Study
11%
Ovary Cancer
11%
Drug Concentration
11%
Hyperbarism
11%
Neuroscience
Ketoconazole
100%
Erythromycin
44%